CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Barry Myers is a featured speaker at CED's MedTech 2008 Conference in Durham, NC
News | 03. 08. 2008
